Emerging like a promising advance in the fight against weight issues, Retatrutide is quickly gaining focus. This new dual activator – affecting both GLP-1 and GIP receptors – exhibits impressive results in clinical studies. Preliminary findings suggest that Retatrutide might offer more weight les